Practical Geriatrics ›› 2024, Vol. 38 ›› Issue (4): 410-413.doi: 10.3969/j.issn.1003-9198.2024.04.019
Previous Articles Next Articles
Received:2023-06-12
Published:2024-04-23
CLC Number:
| [1] JAMESON J L. Harrison's Endocrinology[M]. 3rd ed. New York: McGraw-Hill Education, 2018:171. [2] PARK S K, HARLOW S D, ZHENG H, et al. Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes[J]. Diabet Med, 2017, 34(4):531-538. [3] MUKA T, ASLLANAJ E, AVAZVERDI N, et al. Age at natural menopause and risk of type 2 diabetes: a prospective cohort study[J]. Diabetologia, 2017, 60(10):1951-1960. [4] WANG Y, TANG R, LUO M, et al. Follicle stimulating hormone and estradiol trajectories from menopausal transition to late postmenopause in indigenous Chinese women[J]. Climacteric, 2021, 24(1):80-88. [5] HERBER-GAST G C, MISHRA G D. Early severe vasomotor menopausal symptoms are associated with diabetes[J]. Menopause, 2014, 21(8):855-860. [6] JEONG H G, PARK H. Metabolic disorders in menopause[J]. Metabolites, 2022, 12(10):954. [7] REN Y, ZHANG M, LIU Y, et al. Association of menopause and type 2 diabetes mellitus[J]. Menopause, 2019, 26(3):325-330. [8] MATTHEWS K A, CRAWFORD S L, CHAE C U, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?[J]. J Am Coll Cardiol, 2009, 54(25):2366-2373. [9] JANSSEN I, POWELL L H, CRAWFORD S, et al. Menopause and the metabolic syndrome: the study of women's health across the nation[J]. Arch Intern Med, 2008, 168(14):1568-1575. [10] SORIGUER F, MORCILLO S, HERNANDO V, et al. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study[J]. Menopause, 2009, 16(4):817-821. [11] LIZNEVA D, RAHIMOVA A, KIM S M, et al. FSH beyond fertility[J]. Front Endocrinol (Lausanne), 2019, 19(10):136. [12] 杨帆, 曾凡清, 戚燕妮. 女性围绝经期卵巢储备功能与血糖代谢功能相关性的研究[J]. 中国糖尿病杂志, 2021,29(09):688-691. [13] CHUNG H F, DOBSON A J, HAYASHI K, et al. Ethnic differences in the association between age at natural menopause and risk of type 2 diabetes among postmenopausal women: a pooled analysis of individual data from 13 cohort studies[J]. Diabetes Care, 2023, 46(11):2024-2034. [14] RUTH K S, DAY F R, TYRRELL J, et al. Using human genetics to understand the disease impacts of testosterone in men and women[J]. Nat Med, 2020, 26(2):252-258. [15] ZHANG H, WANG W, ZHAO J, et al. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome[J]. Front Endocrinol (Lausanne), 2023, 9(13):1085656. [16] HAMMES S R, LEVIN E R. Impact of estrogens in males and androgens in females[J]. J Clin Invest, 2019, 129(5):1818-1826. [17] MAGAGNINI M C, CONDORELLI R A, CIMINO L, et al. Does the ketogenic diet improve the quality of ovarian function in obese women?[J]. Nutrients, 2022, 14(19):4147. [18] YUAN S, WANG L, SUN J, et al. Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation[J]. Int J Epidemiol, 2022, 51(6):1931-1942. [19] PERSKY V, ABASILIM C, TSINTSIFAS K, et al. Sex hormones and diabetes in 45- to 74-year-old men and postmenopausal women: the hispanic community health study[J]. J Clin Endocrinol Metab, 2023, 108(7):1709-1726. [20] HE L, FAN B, LI C, et al. Association between body mass index and diabetes mellitus are mediated through endogenous serum sex hormones among menopause transition women: a longitudinal cohort study[J]. Int J Environ Res Public Health, 2023, 20(3):1831. [21] FENG C, JIN Z, SUN L, et al. Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells[J]. Mol Biol Rep, 2019, 46(5):4953-4965. [22] ANAGNOSTIS P, CHRISTOU K, ARTZOUCHALTZI A M, et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis[J]. Eur J Endocrinol, 2019, 180(1):41-50. [23] HONIGBERG M C, ZEKAVAT S M, ARAGAM K, et al. Association of premature natural and surgical menopause with incident cardiovascular disease[J]. Jama, 2019, 322(24):2411-2421. [24] LEBLANC E S, KAPPHAHN K, HEDLIN H, et al. Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative[J]. Menopause, 2017, 24(1):64-72. [25] RUTH K S, DAY F R, HUSSAIN J, et al. Genetic insights into biological mechanisms governing human ovarian ageing[J]. Nature, 2021, 596(7872):393-397. [26] HEIANZA Y, ARASE Y, KODAMA S, et al. Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17)[J]. Diabetes Care, 2013, 36(12):4007-4014. [27] MAIR K M, GAW R, MACLEAN M R. Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension[J]. Pulm Circ, 2020, 10(3):2045894020952019. [28] LI J, LUO M, TANG R, et al. Vasomotor symptoms in aging Chinese women: findings from a prospective cohort study[J]. Climacteric, 2020, 23(1):46-52. [29] RYU K J, PARK H, PARK J S, et al. Vasomotor symptoms: more than temporary menopausal symptoms[J]. J Menopausal Med, 2020, 26(3):147-153. [30] GRAY K E, KATON J G, LEBLANC E S, et al. Vasomotor symptom characteristics: are they risk factors for incident diabetes?[J]. Menopause, 2018, 25(5):520-530. [31] LI J, LIU B, TANG R, et al. Relationship between vasomotor symptoms and metabolic syndrome in Chinese middle-aged women[J]. Climacteric, 2021, 24(2):151-156. [32] TANG R, FAN Y, LUO M, et al. Generaland central obesity are associated with increased severity of the VMS and sexual symptoms of menopause among Chinese women: a longitudinal study[J]. Front Endocrinol (Lausanne), 2022, 26(13):814872. [33] BERMINGHAM K M, LINENBERG I, HALL W L, et al. Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study[J]. EBioMedicine, 2022, 85:104303. [34] YAHAYA T. Role of epigenetics in the pathogenesis and management of type 2 diabetes mellitus[J]. Translation: UTJMS, 2019, 6:20-28. [35] YUMI NORONHA N, DA SILVA RODRIGUES G, HARUMI YONEHARA NOMA I, et al. 14-weeks combined exercise epigenetically modulated 118 genes of menopausal women with prediabetes[J]. Front Endocrinol (Lausanne), 2022, 15(13):895489. [36] ARMENI E, PASCHOU S A, GOULIS D G, et al. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency[J]. Best Pract Res Clin Endocrinol Metab, 2021, 35(6):101561. [37] 中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志, 2023, 58(1):4-21. [38] SAMAMI E, SHAHHOSSEINI Z, ELYASI F. The effects of psychological interventions on menopausal hot flashes: a systematic review[J]. Int J Reprod Biomed, 2022, 20(4):255-272. [39] 潘卫英, 池莹. 心理疏导联合体育锻炼对围绝经期女性主要症状、生存质量及不良情绪的影响[J]. 中国妇幼保健, 2022, 37(11):2104-2107. |
| [1] | WANG Su, ZHAO Yijing, WEI Chenmin, CHEN Kun, CAO Wen, WANG Kun, YANG Yu. Correlation of triglyceride-glucose index with low-density lipoprotein subtypes in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(10): 1002-1006. |
| [2] | GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029. |
| [3] | . [J]. Practical Geriatrics, 2024, 38(10): 1066-1069. |
| [4] | SHAN Zhuzi, WANG Xuefei, WU Haidi, LIU Dongmei, JIANG Hua, TANG Wei, MO Yongzhen, CUI Yan. Study on the relationship between percentage of body fat and blood glucose fluctuation in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(7): 693-696. |
| [5] | LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437. |
| [6] | LIU Tongjun, ZHAO Yajie, HU Jieling, HU Yang, LIANG Wei. Effect of glucose metabolic disorders on serum levels of activin-A [J]. Practical Geriatrics, 2024, 38(5): 495-437. |
| [7] | . [J]. Practical Geriatrics, 2024, 38(5): 521-437. |
| [8] | . [J]. Practical Geriatrics, 2024, 38(5): 529-437. |
| [9] | TANG Yuan, DENG Shufang, HE Yongmei, DAI Yuxuan, LUO Jing. The status of health literacy and correlation with frailty in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(3): 255-259. |
| [10] | HONG Bing, XU Xiao-Wen, YU Wei-Nan, XU Wei, HU Wen. Application of glargine in elderly type 2 diabetic patients during perioperative period [J]. Practical Geriatrics, 2010, 24(2): 132-134. |
| [11] | ZHU Jian-Yi, LV Zhi-Gang, SHI Heng-Chuan. Relationship of serum total homocysteine and macrovascular diseases in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2010, 24(2): 135-137. |
| [12] | WU Hai-Di, BIAN Rong-Wen, HU Yan. Safety and variation of blood potassium during argentine stimulation test in patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2010, 24(2): 138-140. |
| [13] | HU Lan-Ping, GU Ping, WANG Jian, SHAO Jia-Qiang, DU Hong, WANG Yang-Tian, LU Bin, PENG Li. Determination of islet autoantibodies in elderly diabetic patients by immunoblotting test [J]. Practical Geriatrics, 2010, 24(2): 156-158. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
